Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
AVGO remains the week's biggest story. Shares fell roughly 15% after revenue guidance disappointed, wiping an estimated $300bn from its market cap. Options desks flooded with puts on the June 18 chain. Analysts are divided — JP Morgan raised its target to $580 while Macquarie downgraded to Neutral at $437. Short interest sits at just 1.1% of free float. The damage is almost entirely options-driven, not short books.
JPM shares rose today as investors rotated out of mega-cap tech. The move follows weakness across the sector. MSFT drew fresh analyst attention, with one firm arguing the market is undervaluing the stock relative to peers and .
TEM short interest surged 32% in one week to 20.4% of free float. The stock fell 4.3% today. Borrow is tight at 28.9% availability. ROKU saw an even sharper jump — short interest soared 49.4% in a week to 7.9% of float. The stock dropped 3.9% on the day. Availability is extremely high at 4,314%, meaning short sellers face no borrow constraints.
CIEN reports Q2 results today. ORCL headlines next Wednesday. On the insider front, over $230M in CRWV stock was sold by director Jack Cogen following the AI cloud firm's IPO. AMZN is pushing ahead, launching a next-generation robotics expansion across Europe despite the broader tech slump.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
